the beta blocker heart attack trial ( bhat ) is a multicenter , randomized , double-blind , placebo control clinical trial sponsored by the national heart , lung , and blood institute designed to test the effectiveness of regular propranolol administration in reducing total mortality in patients who have survived a recent acute myocardial infarction .
C0027051
heart attack
C0033497
propranolol